Select Page

The latest report on “Allergy Immunotherapy Market (Type – SLIT, and SCIT; Allergy Type – Asthma, Venom Allergy, Allergic Rhinitis, Food Allergy, and Others Allergy Type; Distribution Channel – Retail Pharmacy and Drug Stores, Hospital Pharmacy, and Online Pharmacy): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025.” The global allergy immunotherapy market is projected to grow at a CAGR of 10.5% over the forecast period of 2019-2025.

For More Details Get FREE Sample Pages of this Research Report@

AIT (Allergy Immunotherapy), is referred to as desensitization, it is the only treatment therapy that targets the cause of allergy. According to the WAO (World Allergy Organization), around 10%-40% of the total population of the world in 2013 is suffering from various allergy. AIT is a treatment option for asthma and environmental allergies. It is the ultimate goal to influence the immune system and its natural regulation through complex mechanisms.

The global allergy immunotherapy market is primarily driven by the rising consciousness of the patient’s concern to the allergy treatment. Moreover, the development of novel products and the growing number of allergic patients is expected to fuel market growth in the near future. However, the allergy tablets are able to heal only a particular type of allergen and remain inefficient to avert the progress of asthma and new allergies are expected to hinder the demand for the global allergy immunotherapy market. Nonetheless, increasing awareness among Patients for allergies is anticipated to create a new opportunity for the global allergy immunotherapy market.

On the basis of region, the global allergy immunotherapy market is bifurcated into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Europe has held the largest revenue share of the global allergy immunotherapy market in 2018 and it is expected to be the dominating region in the coming years. Owing to rising in funding for research and development, high awareness, and grants, complimentary medical reimbursement policies. Europe is a highly influensive market for allergy immunotherapy and is estimated to grow at a significant growth rate within the projected years. Promising products of the clinical pipeline, and increasing allergic population. North America accounted for the second-largest market share for the global allergy immunotherapy market in 2018.

Segment Covered

The report on the global allergy immunotherapy market covers segments such as type, allergy type, and distribution channel. On the basis of type, the sub-markets include SLIT and SCIT. On the basis of allergy type, the sub-markets include asthma, venom allergy, allergic rhinitis, food allergy, and other allergy types. On the basis of the distribution channels, the sub-markets include a retail pharmacy and drug stores, hospital pharmacies, and online pharmacy.

Browse Detailed TOC, Description, and Companies Mentioned in Report @

Companies Profiled:

The report provides profiles of the companies in the market such as Aimmune Therapeutics, Biomay, Stallergenes Greer, Abello, Allergy Therapeutics, Merck, Circassia, HAL Allergy, Anergis, and DBV Technologies.

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of the allergy immunotherapy.

=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.